MT1-MMP: A tethered collagenase

Journal of Cellular Physiology

Volumn 200, Issue 1, 2004, Pages 11-19

  Holmbeck, Kenn ^a   Bianco, Paolo ^b   Yamada, Susan ^a   Birkedal Hansen, Henning ^a  

^a NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE 14;

ANIMAL MODEL; BONE GROWTH; BONE REMODELING; CANCER GROWTH; CARTILAGE; ENZYME ACTIVITY; ENZYME DEFICIENCY; ENZYME SPECIFICITY; EXTRACELLULAR MATRIX; MOLAR TOOTH; MOUSE; NONHUMAN; OSTEOPENIA; PHENOTYPE; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; SHORT SURVEY; SKULL; TOOTH ERUPTION;

ANIMALS; BONE AND BONES; CELL MEMBRANE; CELL MOVEMENT; COLLAGENASES; CONNECTIVE TISSUE; EXTRACELLULAR MATRIX; GENE DELETION; HUMANS; MATRIX METALLOPROTEINASE 14; MATRIX METALLOPROTEINASES, MEMBRANE-ASSOCIATED; METALLOENDOPEPTIDASES; NEOPLASM INVASIVENESS;

ANIMALIA;

EID: 2642572799     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.20065     Document Type: Short Survey

References (42)

1. Beertsen W, Holmbeck K, Niehof A, Bianco P, Chrysovergis K, Birkedal-Hansen H, Everts V. 2002. On the role of MT1-MMP, a matrix metalloproteinase essential to collagen remodeling, in murine molar eruption and root growth. Eur J Oral Sci 110(6):445-451.
2. Bergers G, Brekken R, McMahon G, Vu TH, Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z, Hanahan D. 2000. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2(10):737-744.
3. Brinckerhoff CE, Matrisian LM. 2002. Matrix metalloproteinases: A tail of a frog that became a prince. Nat Rev Mol Cell Biol 3(3):207-214.
4. Bullard KM, Lund L, Mudgett JS, Mellin TN, Hunt TK, Murphy B, Ronan J, Werb Z, Banda MJ. 1999. Impaired wound contraction in stromelysin-1-deficient mice. Ann Surg 230(2):260-265.
5. Caterina JJ, Yamada S, Caterina NC, Longenecker G, Holmback K, Shi J, Yermovsky AE, Engler JA, Birkedal-Hansen H. 2000. Inactivating mutation of the mouse tissue inhibitor of metalloproteinases-2 (Timp-2) gene alters proMMP-2 activation. J Biol Chem 275(34):26416-26422.
6. Caterina JJ, Skobe Z, Shi J, Ding Y, Simmer JP, Birkedal-Hansen H, Bartlett JD. 2002. Enamelysin (matrix metalloproteinase 20)-deficient mice display an amelogenesis imperfecta phenotype. J Biol Chem 277(51):49598-49604.
7. Coussens LM, Fingleton B, Matrisian LM. 2002. Matrix metalloproteinase inhibitors and cancer: Trials and tribulations. Science 295(5564):2387-2392.
8. Egeblad M, Werb Z. 2002. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2(3):161-174.
9. Engsig MT, Chen QJ, Vu TH, Pedersen AC, Therkidsen B, Lund LR, Henriksen K, Lenhard T, Foged NT, Werb Z, Delaisse JM. 2000. Matrix metalloproteinase 9 and vascular endothelial growth factor are essential for osteoclast recruitment into developing long bones. J Cell Biol 151(4):879-889.
10. Fata JE, Leco KJ, Voura EB, Yu HY, Waterhouse P, Murphy G, Moorehead RA, Khokha R. 2001. Accelerated apoptosis in the Timp-3-deficient mammary gland. J Clin Invest 108(6):831-841.
11. Gross J, Lapiere CM. 1962. Collagenolytic activity in amphibian tissue: A tissue culture assay. Proc Natl Acad Sci USA 48:1014-1022.
12. Ha HY, Moon HB, Nam MS, Lee JW, Ryoo ZY, Lee TH, Lee KK, So BJ, Sato H, Seiki M, Yu DY. 2001. Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice. Cancer Res 61(3): 984-990.
13. Holmbeck K, Bianco P, Caterina J, Yamada S, Kromer M, Kuznetsov SA, Mankani M, Robey PG, Poole AR, Pidoux I, Ward JM, Birkedal-Hansen H. 1999. MT1-MMP-deficient mice develop dwarfism, osteopenia, arthritis, and connective tissue disease due to inadequate collagen turnover. Cell 99(1):81-92.
14. Hotary KB, Allen ED, Brooks PC, Datta NS, Long MW, Weiss SJ. 2003. Membrane type I matrix metalloproteinase usurps tumor growth control imposed by the three-dimensional extracellular matrix. Cell 114(1):33-45.
15. Itoh T, Ikeda T, Gomi H, Nakao S, Suzuki T, Itohara S. 1997. Unaltered secretion of beta-amyloid precursor protein in gelatinase A (matrix metalloproteinase 2)-deficient mice. J Biol Chem 272(36): 22389-22392.
16. Itoh T, Tanioka M, Yoshida H, Yoshioka T, Nishimoto H, Itohara S. 1998. Reduced angiogenesis and tumor progression in gelatinase A-deficient mice. Cancer Res 58(5):1048-1051.
17. Kang T, Yi J, Yang W, Wang X, Jiang A, Pei D. 2000. Functional characterization of MT3-MMP in transfected MDCK cells: Progelatinase A activation and tubulogenesis in 3-D collagen lattice. Faseb J 14(15):2559-2568.
18. Kolkenbrock H, Hecker-Kia A, Orgel D, Ulbrich N, Will H. 1997. Activation of progelatinase A and progelatinase A/TIMP-2 complex by membrane type 2-matrix metalloproteinase. Biol Chem 378(2): 71-76.
19. Leco KJ, Waterhouse P, Sanchez OH, Gowing KL, Poole AR, Wakeham A, Mak TW, Khokha R. 2001. Spontaneous air space enlargement in the lungs of mice lacking tissue inhibitor of metalloproteinases-3 (TIMP-3). J Clin Invest 108(6):817-829.
20. Li Q, Park PW, Wilson CL, Parks WC. 2002. Matrilysin shedding of syndecan-1 regulates chemokine mobilization and transepithelial efflux of neutrophils in acute lung injury. Cell 111(5):635-646.
21. Lutfi AM. 1970. Mode of growth, fate, and functions of cartilage canals. J Anat 106(1):135-145.
22. Masson R, Lefebvre O, Noel A, Fahime ME, Chenard MP, Wendling C, Kebers F, LeMeur M, Dierich A, Foidart JM, Basset P, Rio MC. 1998. In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy. J Cell Biol 140(6):1535-1541.
23. Morrison CJ, Butler GS, Bigg HF, Roberts CR, Soloway PD, Overall CM. 2001. Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway. J Biol Chem 276(50):47402-47410.
24. Mudgett JS, Hutchinson NI, Chartrain NA, Forsyth AJ, McDonnell J, Singer II, Bayne EK, Flanagan J, Kawka D, Shen CF, Stevens K, Chen H, Trumbauer M, Visco DM. 1998. Susceptibility of stromelysin 1-deficient mice to collagen-induced arthritis and cartilage destruction. Arthritis Rheum 41(1):110-121.
25. Murphy G, Knauper V, Atkinson S, Butler G, English W, Hutton M, Stracke J, Clark I. 2002. Matrix metalloproteinases in arthritic disease. Arthritis Res 4(Suppl 3):S39-S49.
26. Oh J, Takahashi R, Kondo S, Mizoguchi A, Adachi E, Sasahara RM, Nishimura S, Imamura Y, Kitayama H, Alexander DB, Ide C, Horan TP, Arakawa T, Yoshida H, Nishikawa S, Itoh Y, Seiki M, Itohara S, Takahashi C, Noda M. 2001. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 107(6):789-800.
27. Parks WC. 1999. Matrix metalloproteinases in repair. Wound Repair Regen 7(6):423-432.
28. Pei D. 1999. Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP. J Biol Chem 274(13): 8925-8932.
29. Pei D, Weiss SJ. 1995. Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 375(6528):244-247.
30. Pei D, Weiss SJ. 1996. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity. J Biol Chem 271(15):9135-9140.
31. Ryan ME, Golub LM. 2000. Modulation of matrix metalloproteinase activities in periodontitis as a treatment strategy. Periodontology 24:226-238.
32. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M. 1994. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 370(6484):61-65.
33. Seiki M. 2003. Membrane-type 1 matrix metalloproteinase: A key enzyme for tumor invasion. Cancer Lett 194(1):1-11.
34. Shipley JM, Wesselschmidt RL, Kobayashi DK, Ley TJ, Shapiro SD. 1996. Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proc Natl Acad Sci USA 93(9): 3942-3946.
35. Steffensen B, Hakkinen L, Larjava H. 2001. Proteolytic events of wound-healing - Coordinated interactions among matrix metalloproteinases (MMPs), integrins, and extracellular matrix molecules. Crit Rev Oral Biol Med 12(5):373-398.
36. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg GI. 1995. Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 270(10):5331-5338.
37. Takahashi C, Sheng Z, Horan TP, Kitayama H, Maki M, Hitomi K, Kitaura Y, Takai S, Sasahara RM, Horimoto A, Ikawa Y, Ratzkin BJ, Arakawa T, Noda M. 1998. Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proc Natl Acad Sci USA 95(22):13221-13226.
38. Vu TH, Shipley JM, Bergers G, Berger JE, Helms JA, Hanahan D, Shapiro SD, Senior RM, Werb Z. 1998. MMP-9/gelatinase B is a key regulator of growth plate angiogenesis and apoptosis of hypertrophic chondrocytes. Cell 93(3):411-422.
39. Wang M, Qin X, Mudgett JS, Ferguson TA, Senior RM, Welgus HG. 1999. Matrix metalloproteinase deficiencies affect contact hypersensitivity: Stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response. Proc Natl Acad Sci USA 96(12):6885-6889.
40. Wang Z, Juttermann R, Soloway PD. 2000. TIMP-2 is required for efficient activation of proMMP-2 in vivo. J Biol Chem 275(34): 26411-26415.
41. Wilson CL, Heppner KJ, Labosky PA, Hogan BL, Matrisian LM. 1997. Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin. Proc Natl Acad Sci USA 94(4):1402-1407.
42. Zhou Z, Apte SS, Soininen R, Cao R, Baaklini GY, Rauser RW, Wang J, Cao Y, Tryggvason K. 2000. Impaired endochondral ossification and angiogenesis in mice deficient in membrane-type matrix metalloproteinase I. Proc Natl Acad Sci USA 97(8):4052-4057.